CN105063157A - 一种人参皂甙Rh2的合成方法 - Google Patents
一种人参皂甙Rh2的合成方法 Download PDFInfo
- Publication number
- CN105063157A CN105063157A CN201510511480.2A CN201510511480A CN105063157A CN 105063157 A CN105063157 A CN 105063157A CN 201510511480 A CN201510511480 A CN 201510511480A CN 105063157 A CN105063157 A CN 105063157A
- Authority
- CN
- China
- Prior art keywords
- ginsenoside
- cancer
- panaxoside
- ethanolic soln
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种人参皂甙Rh2的合成方法,属医药,化工技术领域,人参皂甙Rh2被称为续命素,黑色素瘤、乳腺癌、卵巢癌、肝癌、肺癌、骨癌、胰腺癌、结肠癌、前列腺癌等癌症患者在治疗和康复过程中的上佳辅助保健食品,本发明通过化学方法来合成和纯化,得到了35%含量的人参皂甙Rh2,市场潜力巨大,且成本低廉,为工业化生产提供了依据。
Description
技术领域
本发明涉及一种人参皂甙Rh2的合成方法,属医药,化工技术领域。
背景技术
人参皂甙Rh2,能提高自身免疫功能,增强抗病能力;是黑色素瘤、乳腺癌、卵巢癌、肝癌、肺癌、骨癌、胰腺癌、结肠癌、前列腺癌等癌症患者在治疗和康复过程中的上佳辅助保健食品。人参皂甙Rh2能够直接介导DNA的合成来诱导肿瘤细胞凋亡。由于人参皂甙Rh2作用癌细胞后,直接抑制了癌细胞的DNA复制和转录能力,使癌细胞的蛋白质合成受阻,从而就会使癌细胞的增殖减慢或停止。本发明通过化学方法来合成和纯化,得到了35%含量的人参皂甙Rh2,市场潜力巨大。
发明内容
本发明通过对人参皂甙Rh2的合成方法的探索和优化,最终得到了合成人参皂甙Rh2的工艺。人参皂甙Rh2是一种重要的医药体。
本发明所述人参皂甙Rh2的合成方法,是采用含有70%人参皂甙Rg3为原料,在30%乙醇溶液中,加入纤维素酶水解48小时后,用D101大孔树酯吸附,然后用70%乙醇溶液洗脱,洗脱液浓缩至干,得产品。
上述人参皂甙Rh2的合成方法,其特征在于:所述采用含有70%人参皂甙Rg3为原料,不单指70%人参皂甙,其范围为40%到70%。
上述人参皂甙Rh2的合成方法,其特征在于:所述30%乙醇溶液,不单指30%乙醇溶液,其范围为10%到90%。
上述人参皂甙Rh2的合成方法,其特征在于:所述70%乙醇溶液洗脱,不单指70%乙醇溶液洗脱,其范围为10%到90%,也包括其它溶剂,如甲醇等。
上述人参皂甙Rh2的合成方法,其特征在于:所述人参皂甙Rh2的合成方法制得:取1Kg含有70%人参皂甙Rg3的原料,悬于30L30%乙醇溶液中,加入200g纤维素酶,回流水解48小时后,冷却至室温,用2KgD101大孔树酯吸附,10L70%乙醇洗脱,洗胶液浓缩至干后,得900g产品,其中人参皂甙Rh2含量为35%,人参皂甙Rg3含量为20%,皂苷元含量为5%。
人参皂甙Rh2的结构如下:
具体实施方式
实施例:
所述人参皂甙Rh2的合成方法制得:取1Kg含有70%人参皂甙Rg3的原料,悬于30L30%乙醇溶液中,加入200g纤维素酶,回流水解48小时后,冷却至室温,用2KgD101大孔树酯吸附,10L70%乙醇洗脱,洗胶液浓缩至干后,得900g产品,其中人参皂甙Rh2含量为35%,人参皂甙Rg3含量为20%,皂苷元含量为5%。
Claims (5)
1.所述人参皂甙Rh2的合成方法,是采用含有70%人参皂甙Rg3为原料,在30%乙醇溶液中,加入纤维素酶水解48小时后,用D101大孔树酯吸附,然后用70%乙醇溶液洗脱,洗脱液浓缩至干,得产品。
2.如权利要求所述人参皂甙Rh2的合成方法,其特征在于:所述采用含有70%人参皂甙Rg3为原料,不单指70%人参皂甙,其范围为40%到70%。
3.如权利要求所述人参皂甙Rh2的合成方法,其特征在于:所述30%乙醇溶液,不单指30%乙醇溶液,其范围为10%到90%。
4.如权利要求所述人参皂甙Rh2的合成方法,其特征在于:所述70%乙醇溶液洗脱,不单指70%乙醇溶液洗脱,其范围为10%到90%,也包括其它溶剂,如甲醇等。
5.如权利要求所述人参皂甙Rh2的合成方法,其特征在于:所述人参皂甙Rh2的合成方法制得:取1Kg含有70%人参皂甙Rg3的原料,悬于30L30%乙醇溶液中,加入200g纤维素酶,回流水解48小时后,冷却至室温,用2KgD101大孔树酯吸附,10L70%乙醇洗脱,洗胶液浓缩至干后,得900g产品,其中人参皂甙Rh2含量为35%,人参皂甙Rg3含量为20%,皂苷元含量为5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510511480.2A CN105063157A (zh) | 2015-08-19 | 2015-08-19 | 一种人参皂甙Rh2的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510511480.2A CN105063157A (zh) | 2015-08-19 | 2015-08-19 | 一种人参皂甙Rh2的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105063157A true CN105063157A (zh) | 2015-11-18 |
Family
ID=54492663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510511480.2A Pending CN105063157A (zh) | 2015-08-19 | 2015-08-19 | 一种人参皂甙Rh2的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105063157A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106319017A (zh) * | 2016-08-29 | 2017-01-11 | 珀莱雅化妆品股份有限公司 | 一种富含人参皂苷rh2的发酵物的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058646A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力制药股份有限公司 | 人参皂苷Rh2提取物及制备方法 |
CN102154428A (zh) * | 2011-01-13 | 2011-08-17 | 佟心 | 一种人参皂苷Rh2的制备方法 |
-
2015
- 2015-08-19 CN CN201510511480.2A patent/CN105063157A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102058646A (zh) * | 2009-11-17 | 2011-05-18 | 天津天士力制药股份有限公司 | 人参皂苷Rh2提取物及制备方法 |
CN102154428A (zh) * | 2011-01-13 | 2011-08-17 | 佟心 | 一种人参皂苷Rh2的制备方法 |
Non-Patent Citations (3)
Title |
---|
JIN-HUAN SU ET AL.: "Improving Enzymatic Production of Ginsenoside Rh2from Rg3 by using Nonionic Surfactant", 《APPL BIOCHEM BIOTECHNOL》 * |
万会达等: "β-半乳糖苷酶选择性催化人参皂苷Rg3水解制备Rh2初探", 《食品与发酵工业》 * |
程慧等: "人参皂苷Rg3与Rh2的研究进展", 《药物评价研究》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106319017A (zh) * | 2016-08-29 | 2017-01-11 | 珀莱雅化妆品股份有限公司 | 一种富含人参皂苷rh2的发酵物的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY193112A (en) | Anti pd-1 and anti-lag3 antibodies for cancer treatment | |
CA3011087A1 (en) | Methods of producing patient-specific anti-cancer therapeutics and methods of treatment therefor | |
WO2008134474A3 (en) | Compositions and methods including cell death inducers and procaspase activation | |
CN105063157A (zh) | 一种人参皂甙Rh2的合成方法 | |
CN105859805A (zh) | 核桃青皮中一种新的酚苷化合物的制备方法和用途 | |
CN104479040A (zh) | 一种竹荪多糖的提取工艺 | |
CN104857245A (zh) | 紫萼玉簪花总皂苷的制备方法和应用 | |
Guerrero-Analco et al. | Bioactive Polysaccharides of North American Ginseng Panax quinquefolius L. in modulation of immune function: preliminary chemical and biological characterization | |
CN104490945A (zh) | 一种治癌超微分子生物药 | |
Chanchao et al. | Mechanism of cardanol isolated from Thai propolis on apoptosis of BT474 breast cancer cells | |
WO2014181115A3 (en) | Cgb2 and cgb1 genes; diagnosis, monitoring and treatment of cancer | |
Xiuliang et al. | Clinical and pathological characteristics of gastrointestinal tumors related to schistosomiasis japonica | |
Mallon et al. | In vitro propagation methods of the succulent plant Euphorbia resinifera and quantification of its major compounds | |
Lai et al. | Antileukemic lanostanoids from Poria cocos | |
Guerra et al. | Anti-tumoral activity of lipophilic Eucalyptus bark extracts, enriched on triterpenic acids, against breast cancer cells | |
Manek et al. | Liquorice exaggerates protective action of Solanum xanthocarpum against cigarette smoke induced pulmonary inflammation | |
Monteiro et al. | Antiproliferative and anti-inflammatory activity of fraction containing terpenes from Croton campestris A. St.-Hil.(Euphorbiaceae) | |
Fong et al. | Asiaticoside reduces TNF-α-induced increased soluble platelet endothelial cell adhesion molecule-1 (sPECAM-1) levels in human aortic endothelial cells | |
Yang et al. | Simultaneous determination of two biflavones in Biyanling tablets by HPLC | |
CN103768106A (zh) | 一种半边旗黄酮提取方法 | |
Alban et al. | Optimized isolation and pharmacological activities of sulfated polysaccharides from the red seaweed Delesseria sanguinea | |
Pei et al. | Inhibition of aquaporin-1 but not aquaporin-4 water permeability by bacopaside I derived from Bacopa monnieri | |
Ronpirin et al. | Inhibitory effect of ethanolic extract of Annona squamosa L. leaves on the expression of EGFR | |
Kim et al. | Effects of fermented Asterina pectinifera using Cordyceps militaris mycelia on antioxidant | |
Grech-Baran et al. | Activity of tyrosol glucosyltransferase in Rhodiola kirilowii transgenic root cultures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 710000 Shaanxi city of Xi'an province high tech Zone Jinye Road No. 69 C District No. 1 gazelle Valley F building 501 room Applicant after: Xi'an Yue biological Polytron Technologies Inc Address before: 710000 Shaanxi city of Xi'an province high tech Zone Jinye Road No. 69 C District No. 1 gazelle Valley F building 501 room Applicant before: Xi'an Day Natural Tech Co., Ltd. |
|
COR | Change of bibliographic data | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151118 |